03.jpg
Melanoma Patients Australia

Home arrow Information arrow Clinical Trials arrow Melanoma Trial - SMU

Melanoma Trial - SMU

News Item

Novel Metabolic Targeting Approach to Melanoma Treament.

 

A Melanoma Trial is being initiated by Professor Hersey from the Sydney Melanoma Unit using a novel NACO formulation. Approval has been obtained to commence trials with Melanoma Stage 4 patients.

Information will be periodically updated on the www.jonpharma.com web site.